Breath-Taking Perspectives and Preliminary Data toward Early Detection of Chronic Liver Diseases

Antonio Murgia, Yusuf Ahmed, Kelly Sweeney, Louise Nicholson-Scott, Kayleigh Arthur, Max Allsworth, Billy Boyle, Olga Gandelman, Agnieszka Smolinska, Giuseppe Ferrandino*

*Corresponding author for this work

Research output: Contribution to journal(Systematic) Review article peer-review

Abstract

The gold standard method for chronic liver diseases diagnosis and staging remains liver biopsy, despite the spread of less invasive surrogate modalities based on imaging and blood biomarkers. Still, more than 50% of chronic liver disease cases are detected at later stages when patients exhibit episodes of liver decompensation. Breath analysis represents an attractive means for the development of non-invasive tests for several pathologies, including chronic liver diseases. In this perspective review, we summarize the main findings of studies that compared the breath of patients with chronic liver diseases against that of control subjects and found candidate biomarkers for a potential breath test. Interestingly, identified compounds with best classification performance are of exogenous origin and used as flavoring agents in food. Therefore, random dietary exposure of the general population to these compounds prevents the establishment of threshold levels for the identification of disease subjects. To overcome this limitation, we propose the exogenous volatile organic compounds (EVOCs) probe approach, where one or multiple of these flavoring agent(s) are administered at a standard dose and liver dysfunction associated with chronic liver diseases is evaluated as a washout of ingested compound(s). We report preliminary results in healthy subjects in support of the potential of the EVOC Probe approach.

Original languageEnglish
Article number1563
Number of pages20
JournalBiomedicines
Volume9
Issue number11
DOIs
Publication statusPublished - 28 Oct 2021

Keywords

  • breath biopsy
  • volatile organic compounds (VOC)
  • chronic liver diseases
  • VOLATILE ORGANIC-COMPOUNDS
  • CHRONIC HEPATITIS-C
  • EXHALED BREATH
  • NITRIC-OXIDE
  • LUNG-CANCER
  • TISSUE INHIBITORS
  • SERUM CONCENTRATIONS
  • SIGNIFICANT FIBROSIS
  • NONINVASIVE MARKERS
  • HYDROGEN-PEROXIDE

Fingerprint

Dive into the research topics of 'Breath-Taking Perspectives and Preliminary Data toward Early Detection of Chronic Liver Diseases'. Together they form a unique fingerprint.

Cite this